Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer’s disease | Center for Neurodegeneration and Translational Neuroscience (CNTN)

Cummings JL, Zhong K, Kinney JW, Heaney C, Moll-Tudla J, Joshi A

Alzheimer’s Res Ther

January 2016

← Back to Publications